Maria Guadalupe Cardenas, MD, is Board Certified in Internal Medicine (NPI #1164426749
We can review your medical history, assess your candidacy for treatment, and explain how our program integrates medication with the nutritional guidance and behavioral support that optimize long-term success
These large-scale, randomised controlled trials evaluated liraglutide 3.0 mg in adults with obesity or overweight, with follow-up periods extending to 56 weeks or longer
Vascular NADPH oxidases as drug targets for novel antioxidant strategies
In other words, antioxidant glutathione doesnt just protect it empowers every other antioxidant in your body to keep working longer and stronger
Athletes should not assume lack of established methods means safety